6505--Alendronate Tablets
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Presolicitation Notice
Page 1 of
Presolicitation Notice
Page 1 of 3
Presolicitation Notice
*=Required Field
Presolicitation Notice
Page 4 of 4
DESCRIPTION
Presolicitation Notice
Presolicitation Notice
Page 3 of 3
Page 1 of 4
Page 1 of 4
Presolicitation Notice
*=Required Field
Presolicitation Notice
Page 1 of 3
Page 1 of
Page 1 of
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0069 for an unrestrictive procurement for Alendronate Tablets for the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC/UPC number. The standard package is a blister pack, but VA will accept unit of use bottles. Solicitation #36E79725R0069 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 28, 2025, with a tentative closing date of November 13, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: www.beta.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Michael Olszewski. Questions can be e-mailed to: Michael.Olszewski@va.gov.
The estimated annual requirements are as follows:
ITEM
DESCRIPTION
PACKAGE SIZE (BOTTLES/BLISTER PACKS)
TOTAL
ESTIMATED
ANNUAL
USAGE
(BOTTLES/BLISTER PACKS)
1
ALENDRONATE 35MG TAB
4
21,300
2
ALENDRONATE 35MG TAB
12
5,354
3
ALENDRONATE 70MG TAB
4
80,074
4
ALENDRONATE 70MG TAB
12
100,609